Botanical species · safety record

Rhodiola rosea

The EFSA Compendium of Botanicals holds 6 constituent measurements and 2 adverse-effect records for Rhodiola rosea. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Rhodiola rosea L.

6Constituent measurements

2Safety records

4Cited sources

1,510Licensed products (Canada)

Also recorded as

Sedum roseum (L.) Scop.

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 1,510 licensed products naming Rhodiola rosea as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Dry
Extract Type TBA
Fresh

Source material stated

Aerial parts extract
Dried root(s)
Herb
New material
Racine
Rhizome
Rhizome and root(s)
Rhodiola rosea

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Cyanogenic glycosides	Roots and other underground parts	Solvent extraction	—	Unspecified	Resolve DOI
Gallic acid	Roots and other underground parts	Solvent extraction	—	Unspecified	Resolve DOI
Phenylpropanoids	Roots and other underground parts	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Proanthocyanidins (condensed tannins)	Roots and other underground parts	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Phenylpropanoids	Roots and other underground parts	Solvent extraction	—	Unspecified	No resolvable identifier
Tannins	Roots and other underground parts	Solvent extraction	—	Unspecified	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Digestive	Digestive	Unspecified	Solvent extraction	—	In vitro	Resolve DOI
Digestive	Digestive	Unspecified	Solvent extraction	—	In vitro	Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Benalla, W., Bellahcen, S., Bnouham, M. Antidiabetic medicinal plants as a source of alpha glucosidase inhibitors. Current diabetes reviews, 2010, vol. 6, no. 4, p. 247-254. DOI
Yousef, Gad G., Grace, Mary H., Cheng, Diana M., Belolipov, Igor V., Raskin, Ilya., Lila, Mary Ann. Comparative phytochemical characterization of three Rhodiola species. PHYTOCHEMISTRY, 2006, vol. 67, no. 21, p. 2380-2391. DOI
Spiridonov, Nikolay A., Konovalov, Dmitrii A., Arkhipov, Vladimir V. Cytotoxicity of some russian ethnomedicinal plants and plant compounds. Phytotherapy Research, 2005, p. 428-432.
Panossian, A., Wikman, G., Sarris, J. Rosenroot (Rhodiola rosea): Traditional use, chemical composition, pharmacology and clinical efficacy . Phytomedicine, 2010, vol. 17, no. 7, p. 481-493. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature